Idoxine Powder contains Cadexomer Iodine 1000mg, a topical antimicrobial agent indicated for the management of chronic wounds, including leg ulcers, pressure sores, and diabetic foot ulcers. Cadexomer Iodine is a slow-release iodine formulation that provides sustained antimicrobial activity by gradually releasing iodine upon contact with wound exudate, thereby reducing bacterial load and promoting a conducive environment for wound healing. The powder form allows for easy application to irregular wound surfaces, facilitating absorption of exudate and debris while maintaining a moist wound environment. Idoxine Powder is effective against a broad spectrum of pathogens, including Gram-positive and Gram-negative bacteria, as well as fungi, and is particularly useful in wounds complicated by infection or heavy exudation. The product should be applied directly to the wound bed after appropriate cleaning, with frequency of dressing changes determined by the level of exudate and clinical response. Caution is advised in patients with iodine sensitivity, thyroid disorders, or those undergoing radioiodine therapy. Idoxine Powder is contraindicated in individuals with known hypersensitivity to iodine or cadexomer iodine. Proper wound assessment and monitoring are essential to optimize therapeutic outcomes and minimize potential adverse effects.